Ashland
ASH
70.67
-0.30
-0.42%
Ashland
US · ASH
#2461 by market cap
Listed 1970
70.67
-0.30
-0.42%
Live - 5344 symbols - heartbeat 398s ago
· 2026-10-08 07:00
Pre-market
70.33
-0.48%
After-hours
70.67
0.00%
- Market cap
- 3.24B
- P/E (TTM)i
- 67.30
- P/Bi
- 1.73
- EPSi
- -18.23
- Div yieldi
- 2.36%
- 52W posi
- 78%
Reader sentiment
Are you bullish or bearish on ASH?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Accumulating
- The number of reporting institutions decreased by 1 in the most recent period (2026/Q3).
- Total institutional ownership rose 2.3 percentage points.
Institutional ownership
- Held by institutions
- 117.44% +2.26pp
- Institutions
- 414 -1
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
DivergingInstitutions added shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Mutual Fund85.08%
Hedge Fund25.88%
Public Company3.02%
Private Company2.07%
Individual/Insider1.22%
Government Pension Fund1.00%
Insurance Company0.18%
Family Office/Trust0.17%
Top holders as of 2026-06-30
BlackRock
12.47% · 5.71M sh
Standard Investments LLC
9.88% · 4.53M sh
Franklin Resources
7.89% · 3.61M sh
Omega Advisors, Inc.
6.37% · 2.92M sh
Dimensional Fund Advisors
5.43% · 2.49M sh
Vanguard Portfolio Management, LLC
5.38% · 2.46M sh
Vanguard Capital Management, LLC
5.17% · 2.37M sh
MFS Investment Management
4.45% · 2.04M sh
Frontier Capital Management
4.37% · 2.00M sh
Ancora Advisors LLC
4.25% · 1.95M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 45 buys · 4 sells
| Name | Role | Stake |
|---|---|---|
| John Willis | Senior Vice President | 0.59% |
| Guillermo Novo | Chairperson & CEO | 0.38% |
| Osama Musa | Chief Technology Officer | 0.08% |
| Susan Main | Independent Director | 0.03% |
| Jerome Peribere | Independent Director | 0.02% |
| Alessandra Assis | Senior VP and GM of Life Sciences & Intermediates | 0.02% |
| Eileen Drury | Chief Human Resources Officer | 0.02% |
| James Minicucci | Senior Vice President of Strategy, Portfolio Management, Mergers & Acquisitions | 0.02% |
| Robin Lampkin | Senior Vice President | 0.02% |
| Karl Bostaph | Officer | 0.02% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-29 | Stephen Bishop | Independent Director | Other Derivative Acquisition | +368 | -- |
| 2026-09-29 | Sanat Chattopadhyay | Director | Other Derivative Acquisition | +212 | -- |
| 2026-09-20 | Osama Musa | Chief Technology Officer | Derivative Exercise and Sale | -3,647 | $69.06 |
| 2026-09-20 | Osama Musa | Chief Technology Officer | Derivative Exercise and Retained | +6,771 | $69.06 |
| 2026-09-14 | Osama Musa | Chief Technology Officer | Other Derivative Acquisition | +14,230 | -- |
| 2026-08-10 | Robin Lampkin | Senior Vice President | Derivative Exercise and Sale | -526 | $74.58 |
| 2026-08-10 | Robin Lampkin | Senior Vice President | Derivative Exercise and Retained | +1,280 | $74.58 |
| 2026-07-28 | Osama Musa | Chief Technology Officer | Derivative Exercise and Retained | +1,267 | $57.96 |
| 2026-07-26 | Allen Spizzo | Independent Director | Other Derivative Acquisition | +978 | -- |
| 2026-07-26 | Peter Thomas | Independent Director | Other Derivative Acquisition | +978 | -- |
| 2026-07-26 | Peter Thomas | Independent Director | Initial Statement of Beneficial | 0 | -- |
| 2026-07-26 | Alessandra Assis | Senior VP and GM of Life Sciences & Intermediates | Derivative Exercise and Sale | -884 | $66.38 |
| 2026-07-26 | Alessandra Assis | Senior VP and GM of Life Sciences & Intermediates | Derivative Exercise and Retained | +2,331 | $66.38 |
| 2026-06-29 | Stephen Bishop | Independent Director | Other Derivative Acquisition | +379 | -- |
| 2026-06-29 | Sanat Chattopadhyay | Director | Other Derivative Acquisition | +218 | -- |
| 2026-05-14 | Bertrand Loy | Independent Director | Other Derivative Acquisition | +1,741 | -- |
| 2026-05-07 | James Minicucci | Senior Vice President of Strategy, Portfolio Management, Mergers & Acquisitions | Derivative Exercise and Sale | -1,346 | $55.01 |
| 2026-05-07 | James Minicucci | Senior Vice President of Strategy, Portfolio Management, Mergers & Acquisitions | Derivative Exercise and Retained | +2,964 | $55.01 |
| 2026-03-30 | Stephen Bishop | Independent Director | Other Derivative Acquisition | +450 | -- |
| 2026-03-30 | Sanat Chattopadhyay | Director | Other Derivative Acquisition | +258 | -- |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 07:00:16 · For reference only, not investment advice and not tailored to your situation.